Accepted Manuscript Title: Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron Author: Jorge E Toblli Federico Di Gennaro Carlos Rivas PII: DOI: Reference:

S1443-9506(15)00034-7 http://dx.doi.org/doi:10.1016/j.hlc.2014.12.161 HLC 1768

To appear in: Received date: Revised date: Accepted date:

17-9-2014 23-12-2014 26-12-2014

Please cite this article as: Toblli JE, Di Gennaro F, Rivas C, Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron, Heart, Lung and Circulation (2015), http://dx.doi.org/10.1016/j.hlc.2014.12.161 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron

Institution (work performed): Hospital Alemán, School of Medicine,

ip t

Authors: Jorge E Toblli, Federico Di Gennaro, Carlos Rivas

us

Corresponding author Jorge E Toblli MD, PhD, FASN.

cr

University of Buenos Aires, Av. Pueyrredon 1640, (1118) Buenos Aires, Argentina

an

Department of Internal Medicine, Hospital Alemán, School of Medicine,

University of Buenos Aires, Av. Pueyrredon 1640, (1118) Buenos Aires, Argentina

M

Email: [email protected] Phone: (+54 11) 4827 7000

te

d

Fax: (+54 11) 4805 6087

Ac ce p

Running title: Iron and ECHO findings in HF and CKD.

1

Page 1 of 27

Abstract Background: Treatment of iron deficiency helps to improve cardiac and renal function in patients with chronic heart failure. However, the mechanism by which this occurs is currently

ip t

unclear. Methods: We undertook a double-blind, randomised, placebo-controlled study of intravenous

cr

iron sucrose treatment (200 mg/mL weekly for five weeks) in patients with chronic heart

failure, chronic kidney disease and iron-deficiency anaemia receiving optimal treatment for

us

chronic heart failure (N=60). Markers of disease severity, iron status, anaemia and

an

inflammation were measured during a six-month follow-up period, and evaluation of echocardiographic parameters was performed at baseline and six months after treatment.

M

Results: At six months after treatment initiation, intravenous iron was associated with reduced severity of the symptoms of chronic heart failure and improved renal function (both

d

p

Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.

Treatment of iron deficiency helps to improve cardiac and renal function in patients with chronic heart failure. However, the mechanism by which this ...
249KB Sizes 0 Downloads 11 Views